On Thursday, May 16, the Pennsylvania Supreme Court examined the level of public awareness regarding the dangers of Risperdal, which can put potential
Pennsylvania’s Supreme Court ruled that lower courts had erred in dismissing two lawsuits from Risperdal patients on statute of limitation grounds
A ruling by a panel of Pennsylvania judges opens the way for about 6,000 plaintiffs with Risperdal lawsuits filed in that state to seek punitive damages from
The proceeding concluded its fifth gynecomastia trial in July, with a jury
In a recent study, Risperdal side effects increased a patient’s chances of developing diabetes by about 50 percent compared to older antipsychotic drugs prescribed for
The Pennsylvania litigation has convened eight Risperdal gynecomastia trials since early 2015
Medical studies have shown that risperidone strongly increases the risk of gynecomastia when administered to children and adolescents
The pharma giant also faced cases in Missouri and California
5 to 3 mg per day As of March 2019, more than 6,700 Risperdal lawsuits had been filed in the Philadelphia Complex Litigation Center (CLC), a special Pennsylvania State court designed to handle large-scale civil trials (also known as mass torts)
history involving a single drug (Risperdal) and the third-largest health care fraud settlement involving one company – is the result of whistleblower lawsuits filed in the Eastern District of Pennsylvania
Pleger $2,500,000 (2015): in 2015 Austin Pledger took his Risperdal lawsuit against Janssen to trial and was awarded $2
Risperidone (Risperdal) is an atypical antipsychotic prescription medication commonly used to treat mental health symptoms and disorders, such as schizophrenia, symptoms of irritability in autism, and bipolar mania
Other A jury at Philadelphia Court of Common Pleas has ordered Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals to pay $8bn in punitive damages over its marketing of Risperdal, an anti-psychotic drug
(888) 849-5117 Get answers about a
In the first three months of 2017, more than 3,000 additional Risperdal lawsuits were filed in the Philadelphia
RISPERDAL® is an atypical antipsychotic agent indicated for: •Treatment of schizophrenia in adults and adolescents aged 13-17 years (1
Trial attorney Thomas Kline said litigation over the weed-killer Roundup is "going to Risperdal FDA Approval History
Drowsiness, dizziness, lightheadedness, drooling, nausea, weight gain, or tiredness may occur